CD274
structural variants for guiding treatment with PD-1 blockade in a patient with relapsed/refractory chronic active EBV transformed to NK lymphoma
Leuk Lymphoma
.
2025 Jan;66(1):159-162.
doi: 10.1080/10428194.2024.2404954.
Epub 2024 Sep 18.
Authors
S Robinson
1
2
,
S Wu
1
,
S Lade
1
,
C S Tam
3
4
,
E Wong
5
,
A Khot
2
6
,
P Blombery
1
2
6
Affiliations
1
Department of Pathology, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
2
Clinical Hematology, Peter MacCallum Cancer Center/Royal Melbourne Hospital, Melbourne, Victoria, Australia.
3
Hematology Department, Alfred Hospital, Melbourne, Victoria, Australia.
4
Central Clinical School, Monash University, Melbourne, Victoria, Australia.
5
Department of Clinical Hematology, Austin Health, Melbourne, Victoria, Australia.
6
The University of Melbourne, Melbourne, Victoria, Australia.
PMID:
39291921
DOI:
10.1080/10428194.2024.2404954
No abstract available